Genekam Biotechnology AG
  1. Companies
  2. Genekam Biotechnology AG
  3. Services
  4. T-cell Immunotherapy Solution - Car ...

T-cell Immunotherapy Solution - Car T-cell Therapy Services

SHARE

There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number of T cells (CD4 / CD8) from blood or other source. This isolation kit will generate larger number of needed T cells against number of cells generated through density gradient methods (also called Ficolle), Magnetic beads based Kits are for separation of wanted T cells from other unwanted cells. After that they can be stimulated or undergo the cloning with specific vectors carrying specific sequences. Genekam has developed a kit, which can remove the unwanted erythrocytes, which may be disturbing factors during the development. This can accelerate the development of CAR T-cells therapies against any possible target in field oncology, virology or transplantation medicine. These kits help to make therapies economically.